Duo Partnership Adherence Commitment Therapy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

288 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-08-14

Study Completion Date

2022-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a randomized controlled trial of a new behavioral intervention designed to improve engagement in HIV care for couples. Investigators will compare the HIV viral load outcomes of couples randomized to a couples-based adherence intervention (DuoPACT) or to an individual adherence intervention (LifeSteps).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

DuoPACT Pilot Intervention

NCT02181881

HIV/AIDS

COMPLETED NA

Brief Acceptance-Based Retention Intervention for Newly Diagnosed HIV Patients

NCT04201288

HIV/AIDS

COMPLETED NA

A Pilot Study to Examine Efficacy of Peer Mentoring in Promoting Medication Adherence Among People Living With HIV/AIDS

NCT02025322

HIV

UNKNOWN NA

Pilot Test of a Couple-Based Medication Adherence Intervention for HIV-Positive Women and Their Male Partners in South Africa

NCT03809364

Human Immunodeficiency Virus

COMPLETED NA

HIV Prevention Intervention for People Living With HIV/AIDS

NCT01061021

HIV Infections

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators will test the intervention to improve HIV care engagement by enrolling 150 sexual or gender minority couples and randomizing 75 couples each to one of two conditions: 1) DuoPACT, a newly-developed couples intervention; or 2) LifeSteps, a standardized antiretroviral adherence intervention for HIV+ individuals. After randomization, intervention sessions will be delivered weekly (6 DuoPACT sessions, or 3 Life Steps sessions). All couples will be assessed pre/post intervention to evaluate intervention effects via behavioral indicators of engagement in HIV care, the couple's relationship dynamics, and the primary outcome of HIV viral load.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV/AIDS

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

DuoPACT

A 6-session HIV medication adherence support program for couples.

Group Type ACTIVE_COMPARATOR

DuoPACT

Intervention Type BEHAVIORAL

6 couple-based intervention sessions are administered weekly by a counselor.

LifeSteps

A 3-session HIV medication adherence support program for individuals.

Group Type ACTIVE_COMPARATOR

LifeSteps

Intervention Type BEHAVIORAL

3 individual-based intervention sessions are administered weekly by a counselor.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

DuoPACT

6 couple-based intervention sessions are administered weekly by a counselor.

Intervention Type BEHAVIORAL

LifeSteps

3 individual-based intervention sessions are administered weekly by a counselor.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. 18+ years old;
2. Identifies as a sexual or gender minority;
3. In a primary romantic relationship for at least 3 months;
4. At least one partner is HIV+;
5. English-speaking;
6. Able to provide informed consent; and
7. For HIV+ participants: Evidence of suboptimal engagement in HIV care.

Exclusion Criteria

1. Must be able to consent to and follow study protocol;
2. Evidence of severe cognitive impairment or active psychosis;
3. Lives outside California or plans to relocate from the state of California in the next 6 months; or
4. Participation in the DuoPACT pilot.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No